109 related articles for article (PubMed ID: 28940869)
1. Cytopathological and immunocytochemical findings of pancreatic anaplastic carcinoma with ZEB1 expression by means of touch imprint cytology.
Naito Y; Kawahara A; Taira T; Takase Y; Murata K; Ishida Y; Okabe Y; Tanigawa M; Mihara Y; Nakayama M; Shimamatsu K; Yano H; Akiba J
Diagn Cytopathol; 2018 Feb; 46(2):198-203. PubMed ID: 28940869
[TBL] [Abstract][Full Text] [Related]
2. Expression of Epithelial-Mesenchymal Transition Proteins in Pancreatic Anaplastic (Undifferentiated) Carcinoma.
Ishida K; Yamashita R; Osakabe M; Uesugi N; Yamada N; Nitta H; Fujishima F; Motoi F; Suzuki H; Shimamura H; Noda Y; Sawai T; Unno M; Sasano H; Sasaki A; Sugai T
Pancreas; 2019 Jan; 48(1):36-42. PubMed ID: 30451796
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of Zinc finger E-box binding homeobox 1 (ZEB1) expression in cancer cells and cancer-associated fibroblasts in pancreatic head cancer.
Bronsert P; Kohler I; Timme S; Kiefer S; Werner M; Schilling O; Vashist Y; Makowiec F; Brabletz T; Hopt UT; Bausch D; Kulemann B; Keck T; Wellner UF
Surgery; 2014 Jul; 156(1):97-108. PubMed ID: 24929761
[TBL] [Abstract][Full Text] [Related]
4. Wide expression of ZEB1 in sarcomatous component of spindle cell carcinoma of the esophagus.
Nakazawa T; Nobusawa S; Ikota H; Kuwano H; Takeyoshi I; Yokoo H
Pathol Int; 2015 Dec; 65(12):635-43. PubMed ID: 26515382
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of the expression of E-cadherin and ZEB1 in non-small cell lung cancer.
Matsubara D; Kishaba Y; Yoshimoto T; Sakuma Y; Sakatani T; Tamura T; Endo S; Sugiyama Y; Murakami Y; Niki T
Pathol Int; 2014 Nov; 64(11):560-8. PubMed ID: 25347933
[TBL] [Abstract][Full Text] [Related]
6. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-mesenchymal transition markers in malignant ovarian germ cell tumors.
Solheim O; Førsund M; Tropé CG; Kraggerud SM; Nesland JM; Davidson B
APMIS; 2017 Sep; 125(9):781-786. PubMed ID: 28585395
[TBL] [Abstract][Full Text] [Related]
8. Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer.
Galván JA; Zlobec I; Wartenberg M; Lugli A; Gloor B; Perren A; Karamitopoulou E
Br J Cancer; 2015 Jun; 112(12):1944-50. PubMed ID: 25989272
[TBL] [Abstract][Full Text] [Related]
9. ZEB1 expression is associated with prognosis of intrahepatic cholangiocarcinoma.
Terashita K; Chuma M; Hatanaka Y; Hatanaka K; Mitsuhashi T; Yokoo H; Ohmura T; Ishizu H; Muraoka S; Nagasaka A; Tsuji T; Yamamoto Y; Kurauchi N; Shimoyama N; Toyoda H; Kumada T; Kaneoka Y; Maeda A; Ogawa K; Natsuizaka M; Kamachi H; Kakisaka T; Kamiyama T; Taketomi A; Matsuno Y; Sakamoto N
J Clin Pathol; 2016 Jul; 69(7):593-9. PubMed ID: 26670746
[TBL] [Abstract][Full Text] [Related]
10. ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.
Ma Y; Zheng X; Zhou J; Zhang Y; Chen K
Int J Clin Exp Pathol; 2015; 8(9):11258-67. PubMed ID: 26617850
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-to-mesenchymal transition (EMT) in intraductal papillary mucinous neoplasm (IPMN) is associated with high tumor grade and adverse outcomes.
Lahat G; Lubezky N; Loewenstein S; Nizri E; Gan S; Pasmanik-Chor M; Hayman L; Barazowsky E; Ben-Haim M; Klausner JM
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S750-7. PubMed ID: 25069861
[TBL] [Abstract][Full Text] [Related]
12. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
[TBL] [Abstract][Full Text] [Related]
14. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
[TBL] [Abstract][Full Text] [Related]
15. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer.
Aghdassi A; Sendler M; Guenther A; Mayerle J; Behn CO; Heidecke CD; Friess H; Büchler M; Evert M; Lerch MM; Weiss FU
Gut; 2012 Mar; 61(3):439-48. PubMed ID: 22147512
[TBL] [Abstract][Full Text] [Related]
16. The mir-675-5p regulates the progression and development of pancreatic cancer via the UBQLN1-ZEB1-mir200 axis.
Wang J; Zhang Y; Wei H; Zhang X; Wu Y; Gong A; Xia Y; Wang W; Xu M
Oncotarget; 2017 Apr; 8(15):24978-24987. PubMed ID: 28212565
[TBL] [Abstract][Full Text] [Related]
17. Differential Regulation of ZEB1 and EMT by MAPK-Interacting Protein Kinases (MNK) and eIF4E in Pancreatic Cancer.
Kumar K; Chow CR; Ebine K; Arslan AD; Kwok B; Bentrem DJ; Eckerdt FD; Platanias LC; Munshi HG
Mol Cancer Res; 2016 Feb; 14(2):216-27. PubMed ID: 26609108
[TBL] [Abstract][Full Text] [Related]
18. KDM4B promotes epithelial-mesenchymal transition through up-regulation of ZEB1 in pancreatic cancer.
Li S; Wu L; Wang Q; Li Y; Wang X
Acta Biochim Biophys Sin (Shanghai); 2015 Dec; 47(12):997-1004. PubMed ID: 26511091
[TBL] [Abstract][Full Text] [Related]
19. [Two cases of anaplastic carcinoma of the pancreas in terms of the diversity of carcinoma cells (epithelial-mesenchymal transition; EMT)].
Okamoto M; Kitajima S; Negishi R; Maehata T; Kouro T; Yamauchi S; Takahashi H; Katakura Y; Watanabe Y; Abiko R; Nakaya S; Inaba H; Takano T; Suzuki M; Itoh F
Nihon Shokakibyo Gakkai Zasshi; 2008 Nov; 105(11):1656-65. PubMed ID: 18987452
[TBL] [Abstract][Full Text] [Related]
20. Zinc finger E-box-binding homeobox 1 mediates aerobic glycolysis
Xu WY; Hu QS; Qin Y; Zhang B; Liu WS; Ni QX; Xu J; Yu XJ
World J Gastroenterol; 2018 Nov; 24(43):4893-4905. PubMed ID: 30487699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
